AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review
Authors:
- 7 February 2022
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 24 (4) , 377-382
Abstract
Purpose of Review Management of intracardiac masses, such as right heart thrombi and catheter-related vegetations, can be challenging. Many patients are high-risk candidates for surgical extraction due to multiple comorbidities and risk of distal embolization. In this review, we highlight the advancements in percutaneous approaches for treatment of intracardiac masses utilizing AngioVac (AngioDynamic, Latham, NY). Recent Findings With the Food and Drug Administration (FDA) approval of the AngioVac System in 2009, a growing body of evidence has proven it to be a feasible and effective tool to extract thrombi and masses from the iliocaval system and the right heart. Summary In this review, we highlight the feasibility of AngioVac System (AngioDynamic, Latham, NY) based on the published cases series and registries. Future randomized controlled trials are needed to establish an algorithmic approach in treating intracardiac masses.Keywords
This publication has 29 references indexed in Scilit:
- Venous Thromboembolic Disease: The Use of the Aspiration Thrombectomy Device AngioVacSeminars in Interventional Radiology, 2015
- Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011JACC, 2015
- Thrombectomy using suction filtration and veno‐venous bypass: Single center experience with a novel deviceCatheterization and Cardiovascular Interventions, 2014
- Infective endocarditis prophylaxisOral Diseases, 2014
- Vacuum Assisted Vegetation Extraction for the Management of Large Lead VegetationsJournal of Cardiac Surgery, 2013
- Pathological study of primary cardiac and pericardial tumours in a specialist UK Centre: surgical and autopsy seriesCardiovascular Pathology, 2010
- Characterization and Management of Cardiac TumorsSeminars in Cardiothoracic and Vascular Anesthesia, 2010
- Infective endocarditisThe Lancet, 2004
- Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli.Circulation, 1994
- Primary tumors and cysts of the heart and pericardiumCurrent Problems in Cardiology, 1979